Lowry–MacLean syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Lowry–MacLean syndrome
File:Autosomal dominant - en.svg
Synonyms	LMC syndrome
Pronounce
Specialty	Medical genetics
Symptoms	Intellectual disability, short stature, craniofacial dysmorphism
Complications	N/A
Onset
Duration
Types
Causes	Genetic mutation
Risks
Diagnosis	Clinical diagnosis, genetic testing
Differential diagnosis
Prevention
Treatment	Supportive care, symptomatic treatment
Medication
Prognosis
Frequency
Deaths

Lowry–MacLean Syndrome is a rare genetic disorder characterized by a combination of neurological, dermatological, and developmental abnormalities. It is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.

Clinical Features

Individuals with Lowry–MacLean Syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

• Neurological Abnormalities: These may include seizures, developmental delay, and intellectual disability. Some patients may also exhibit ataxia or other movement disorders.
• Dermatological Manifestations: Affected individuals often have distinctive skin findings, such as hypopigmentation or hyperpigmentation, and may develop cutaneous lesions.
• Developmental Issues: Delayed motor skills and speech development are frequently observed. Some children may also have learning disabilities.

Genetic Basis

Lowry–MacLean Syndrome is caused by mutations in a specific gene, which has yet to be fully identified. The disorder follows an autosomal dominant inheritance pattern, as depicted in the diagram. This means that an affected individual has a 50% chance of passing the mutated gene to their offspring.

Diagnosis

Diagnosis of Lowry–MacLean Syndrome is primarily clinical, based on the characteristic symptoms and family history. Genetic testing can be used to confirm the diagnosis by identifying the specific mutation responsible for the disorder.

Management

There is currently no cure for Lowry–MacLean Syndrome, and treatment is symptomatic and supportive. Management strategies may include:

• Neurological Care: Anticonvulsant medications may be prescribed to control seizures. Physical and occupational therapy can help improve motor skills.
• Dermatological Treatment: Skin lesions may be managed with topical treatments or other dermatological interventions.
• Developmental Support: Early intervention programs, including speech and behavioral therapy, can assist in maximizing developmental potential.

Prognosis

The prognosis for individuals with Lowry–MacLean Syndrome varies depending on the severity of symptoms. With appropriate management, many individuals can lead fulfilling lives, although they may require ongoing medical and supportive care.

See also

• Genetic disorder
• Autosomal dominant
• Neurological disorder
• Dermatology